This evidence has been observed for breast cancers, where it has been shown that poorly differentiated, more aggressive tumors (histological grade 3) have an increased number of CSCs than well differentiated (histological grade 1) tumors (Pece et al, 2010).
It has recently been shown that modulation of STING can lead to an aggressive antitumor response.
Similarly, it was shown that highly aggressive melanoma cells, when seeded on three-dimensional matrices of collagen I, form extracellular matrix-rich patterned networks that surround clusters of tumor cells; however, under the same culture conditions, poorly aggressive melanoma cells did not form the patterned networks [ 38].
It is shown that the most aggressive controller can be set to be a nominal controller designed without any regard to the saturation bounds, resulting in an anti-windup scheme.
It was shown that excessive addition of H2O2 causes aggressive etching that would break the graphene sheets into small pieces [23].
Herein it is shown that decreased TM expression could predict the aggressive tumor growth and advanced clinical stage in bladder cancer.
In a larger series of patients with aggressive RRMS, it was shown that all of the patients were free from progression, and 62% of patients were free from disease activity at +3 years.
It has been shown previously that downregulation of twist in aggressive breast cancer cell lines leads to an abrogation of the invasive and metastatic phenotype of the cells and furthermore twist expression is associated with high grade breast tumors [ 3, 29].
A slight delay in achieving the goal parameter in the GD-RL group was found to be acceptable under the circumstances, particularly since it has been shown in a previous study that early aggressive fluid administration during surgery with crystalloids (> 20 mL/kg per hour) did not improve intestinal tissue oxygen tension compared with fluid restriction [ 25].
Carvalho et al. [ 17] have shown that aggressive periodontitis is associated with markers in BRINP3 (bone morphogenetic protein/ retinoic acid inducible neural-specific 3, previously referred as FAM5C).
